PODCAST

CME

ReachMD

science & medicine medicine

All Episodes

00:00:00

MET and Other Emerging Targets in Metastatic NSCLC

CME ·

2025/07/31

Host: Stephen Liu, MD Guest: Joshua K. Sabari, MD Guest: Susan Scott, MD The rapid pace of therapeutic advances in lung cancer (LC) demands continual learning and adaptation from oncology clinicians. With new agents, indications, and biomarker-driven strategies emerging at an unprecedented rate, staying current is essential to delivering optimal care—but also increasingly challenging. This microlearning-based activity is designed to distill key clinical topics in a unique and

00:00:00

Emerging Therapeutic Developments in Non-Targetable...

CME ·

2025/07/31

00:00:00

Applications of Emerging Data in Resectable NSCLC

CME ·

2025/07/31

00:00:00

Strategies in EGFR-mutated Unresectable Stage III NSCLC

CME ·

2025/07/31

00:00:00

HER2-Driven Strategies in Metastatic NSCLC

CME ·

2025/07/31

00:00:00

Novel Therapies in Extensive-Stage Small Cell Lung...

CME ·

2025/07/31

00:00:00

Updates in Limited-Stage Small Cell Lung Cancer...

CME ·

2025/07/31

00:00:00

The Current Therapeutic Landscape in Unresectable...

CME ·

2025/07/31

00:00:00

Addressing CKM Mortality & Morbidity in Patients With...

CME ·

2025/07/30

Guest: Rajiv Agarwal, MBBS, MD, FASN, BRCU Guest: Amy Mottl, MD, MPH Guest: Muthiah Vaduganathan, MD, MPH This three-part panel series explores how emerging evidence from the CONFIDENCE trial is shaping the future of cardio-kidney-metabolic (CKM) care. In Chapter 1, the experts discuss the additive benefits and safety of combining a nonsteroidal MRA and an SGLT2 inhibitor. Chapter 2 focuses on patient selection and individualized strategies for initiating combination therapy

00:00:00

ADCs Across the Spectrum of HER2 Expression in...

CME ·

2025/07/29

Guest: Reshma L. Mahtani, DO In this Virtual Case Clinic, explore three patient case examples with Dr. Mahtani as she demonstrates the application of the latest clinical evidence in HER2-positive, HER2-low, and HER2-ultralow metastatic breast cancer. By illustrating the use of antibody-drug conjugates in HER2-expressing disease, participants will gain insights into optimal evidence-based treatment selection based upon HER2 expression.

00:00:00

Expert Perspectives on Nonsteroidal MRAs and...

CME ·

2025/06/20

Guest: Muthiah Vaduganathan, MD, MPH Guest: Anuradha Lala-Trindade, MD Guest: Brendon Neuen, MBBS, PhD Heart failure with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF) represent a significant and growing burden for patients and the healthcare system, not only in cardiovascular medicine, but also in the context of cardio-kidney-metabolic (CKM) syndrome. Trials are underway evaluating new therapies that may offer benefits to patients with

00:00:00

Integrating IV Iron into Cancer Care: An Expert...

CME ·

2025/06/11

Host: Brian P. McDonough, MD, FAAFP Guest: George M. Rodgers, MD, PhD Guest: Patricia A. Ford, MD Designed as a dynamic, intensive, and innovative web-based activity, this session will take learners on an in-depth exploration of cancer-related anemia (CRA) and chemotherapy-induced anemia (CIA) as disease states of vast clinical significance, emphasizing the robust prevalence, pathophysiology, and patient burden of CRA/CIA, as well as the prominent role of iron deficiency (ID)

00:00:00

The Latest in Stroke Risk Reduction Strategies: Are...

CME ·

2025/06/11

Host: Alejandro A. Rabinstein, MD, FAHA Guest: Richard E. Pratley, MD Guest: Jay H. Shubrook, DO, FACOFP, FAAFP Listen to expert faculty discuss the role of GLP-1RAs in reducing stroke risk for patients with type 2 diabetes in this on-demand webcast with accompanying slides

00:00:00

Taking Action in Moderate to Severe Pediatric Atopic...

CME ·

2025/06/11

Host: Jennifer Schoch, MD, FAAD On-demand webcast of expert faculty presentation on improving outcomes for pediatric patients with atopic dermatitis, including strategies for implementing systemic therapies and using patient-reported/caregiver-reported outcomes to deliver person-centered care.

00:00:00

When and Why to Use CAC Scoring

CME ·

2025/06/10

Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Guest: Rishi Wadhera, MD, MPP, Mphil Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular

00:00:00

Statins and Safety: What the Data Say About Dementia,...

CME ·

2025/06/10

00:00:00

The Dose Matters: Optimizing Statin Intensity in...

CME ·

2025/06/10

00:00:00

Closing the Loop: Practical Strategies for Timely...

CME ·

2025/06/10

00:00:00

Personalizing LDL-C Treatment—Novel Options That...

CME ·

2025/06/10

00:00:00

Target in Sight: Escalating Therapy to Reach LDL-C Goals

CME ·

2025/06/10

299 results

CME

All Episodes

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe